Forian Inc. (FORA)
NASDAQ: FORA · Real-Time Price · USD
1.890
-0.065 (-3.32%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Company Description
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries.
It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
The company’s subscription and services-based solutions cover the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries.
Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.
Forian Inc.
Country | United States |
Founded | 2014 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 37 |
CEO | Max Wygod |
Contact Details
Address: 41 University Drive, Suite 400 Newtown, Pennsylvania 18940 United States | |
Phone | 267 225 6263 |
Website | forian.com |
Stock Details
Ticker Symbol | FORA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001829280 |
CUSIP Number | 34630N106 |
ISIN Number | US34630N1063 |
Employer ID | 85-3467693 |
SIC Code | 7374 |
Key Executives
Name | Position |
---|---|
Max C. Wygod | Co-Founder, Chief Executive Officer, President and Executive Chairman of the Board |
Michael Vesey CPA | Chief Financial Officer |
Edward Francis Spaniel Jr. | Executive Vice President, General Counsel and Secretary |
Adam H. Dublin | Co-Founder, Chief Strategy Officer and Director |
Jason Holden | Vice President of Corporate Development |
Paul Reuscher | Chief Commercial Officer |
Jeff Forringer | President of Kyber Data Science |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 11, 2025 | 10-K | Annual Report |
Apr 1, 2025 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Mar 31, 2025 | 8-K | Current Report |
Feb 14, 2025 | SCHEDULE 13G/A | Filing |
Feb 13, 2025 | SCHEDULE 13G/A | Filing |
Jan 27, 2025 | SCHEDULE 13D | Filing |
Jan 16, 2025 | 8-K/A | [Amend] Current report |
Nov 13, 2024 | 10-Q | Quarterly Report |
Nov 13, 2024 | 8-K | Current Report |
Nov 6, 2024 | 8-K | Current Report |